Strelia advised Newton Biocapital on the deal. Newton Biocapital acted as lead investor in the 20 million series A investment round in NeuVasQ Biotechnologies, a spin-off of...
Strelia advised Newton Biocapital on the deal. Newton Biocapital acted as lead investor in the 20 million series A investment round in NeuVasQ Biotechnologies, a spin-off of...
You must be a Standard 1 Year member to access this content.